Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Abzena Ltd.

Headquarters: San Diego, CA, United States of America
Year Founded: 2001
Status: Private

BioCentury | Feb 28, 2025
Management Tracks

Indivior CEO exits as activist shareholder Oaktree presses for change

Plus: Paul Hitchin succeeds Laetitia Rouxel as CFO of Evotec, and updates from Elekta, Forx, Abzena and more
BioCentury | Jan 27, 2023
Management Tracks

Hall becomes CEO of Innocoll

Plus: Henderson named CFO at Apogee, and updates from Cerebral and Element
BioCentury | Jan 5, 2023
Management Tracks

Sanofi’s Sarchi heads to Replimune

Plus: Albers joins Atlas, new CBO at Altimmune and updates from Nuvig, Zymeworks, Fulcrum, Step, Charm, Kymera and more
BioCentury | Sep 15, 2014
Company News

Abzena, UCL deal

BioCentury | Jul 21, 2014
Company News

Synthon, Abzena deal

BioCentury | Jul 14, 2014
Financial News

Abzena Ltd completes IPO

BioCentury | Jul 14, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Jul 7, 2014
Financial News

Abzena raises L20 million in London IPO

BioCentury | Jun 23, 2014
Financial News

Abzena proposes IPO

BioCentury | Jun 23, 2014
Finance

Abzena's AIM

Abzena follows in footsteps of other U.K. service plays by listing on AIM
Items per page:
1 - 10 of 14
Help Center
Username
Request a Demo
Request Training
Ask a Question